Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000252218 (LOC124900224) encodes a small Cajal body-specific RNA (scaRNA), a type of non-coding RNA involved in the modification and processing of other small nuclear RNAs (snRNAs) within the Cajal bodies of the nucleus. Such molecules do not encode proteins and are generally not direct therapeutic targets or disease-associated markers[13]. No evidence supports a role for this gene in coding any clinically actionable molecule, nor does it have a mechanism of action for drug interaction. Most clinical and pharmacological databases do not include this gene as a target, and it does not belong to common molecular families such as receptors, enzymes, ion channels, or transcription factors. Due to its non-coding RNA nature, this is not considered a therapeutic target or receptor under typical biomedical definitions. There is nothing to indicate this entry is misspelled, but its use as a "target" is incorrect per conventional drug discovery and clinical target criteria[13].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small Cajal body-specific RNA (scaRNA) (LOC124900224).